Differential effects on cell motility, embryonic stem cell self-renewal and senescence by diverse Src kinase family inhibitors

Experimental Cell Research

Volumn 318, Issue 4, 2012, Pages 336-349

  Tamm, Christoffer ^a   Galitó, Sara Pijuan ^a   Annerén, Cecilia ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Aurora kinase; Cross selectivity; Embryonic stem cells; PD173952; PP2; Src kinase; SU6656

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; AURORA A KINASE; AURORA B KINASE; AURORA C KINASE; IMATINIB; PD 173952; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL AGING; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; COLONY FORMATION; CONTACT INHIBITION; CYTOFLUOROMETRY; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; FIBROBLAST; IMMUNOCYTOCHEMISTRY; KARYOTYPING; MITOSIS INHIBITION; MOUSE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL;

EID: 84856097900     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.12.008     Document Type: Article

References (47)

1. Cohen P. Protein kinases-the major drug targets of the twenty-first century?. Nat. Rev. Drug Discov. 2002, 1:309-315.
2. Karaman M.W., Herrgard S., Treiber D.K., Gallant P., Atteridge C.E., Campbell B.T., Chan K.W., Ciceri P., Davis M.I., Edeen P.T., Faraoni R., Floyd M., Hunt J.P., Lockhart D.J., Milanov Z.V., Morrison M.J., Pallares G., Patel H.K., Pritchard S., Wodicka L.M., Zarrinkar P.P. A quantitative analysis of kinase inhibitor selectivity. Nat. Biotechnol. 2008, 26:127-132.
3. Anneren C., Cowan C.A., Melton D.A. The Src family of tyrosine kinases is important for embryonic stem cell self-renewal. J. Biol. Chem. 2004, 279:31590-31598.
4. Ernst M., Gearing D.P., Dunn A.R. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J. 1994, 13:1574-1584.
5. Meyn M.A., Schreiner S.J., Dumitrescu T.P., Nau G.J., Smithgall T.E. SRC family kinase activity is required for murine embryonic stem cell growth and differentiation. Mol. Pharmacol. 2005, 68:1320-1330.
6. Meyn M.A., Smithgall T.E. Chemical genetics identifies c-Src as an activator of primitive ectoderm formation in murine embryonic stem cells. Sci. Signal. 2009, 2:ra64.
7. Smith Culture and differentiation of embryonic stem cells. Methods Cell Sci. 1991, 13:89-94.
8. Klinghoffer R.A., Sachsenmaier C., Cooper J.A., Soriano P. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 1999, 18:2459-2471.
9. Sakaue-Sawano A., Kurokawa H., Morimura T., Hanyu A., Hama H., Osawa H., Kashiwagi S., Fukami K., Miyata T., Miyoshi H., Imamura T., Ogawa M., Masai H., Miyawaki A. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 2008, 132:487-498.
10. Wang W., Martindale J.L., Yang X., Chrest F.J., Gorospe M. Increased stability of the p16 mRNA with replicative senescence. EMBO Rep. 2005, 6:158-164.
11. Dussault N., Simard C., Neron S., Cote S. Human B lymphocytes and non-Hodgkin's lymphoma cells become polyploid in response to the protein kinase inhibitor SU6656. Blood Cells Mol. Dis. 2007, 39:130-134.
12. Kaminska J., Klimczak-Jajor E., Skierski J., Bany-Laszewicz U. Effects of inhibitor of Src kinases, SU6656, on differentiation of megakaryocytic progenitors and activity of alpha1,6-fucosyltransferase. Acta Biochim. Pol. 2008, 55:499-506.
13. Lannutti B.J., Blake N., Gandhi M.J., Reems J.A., Drachman J.G. Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood 2005, 105:3875-3878.
14. Fu J., Bian M., Jiang Q., Zhang C. Roles of Aurora kinases in mitosis and tumorigenesis. Mol. Cancer Res. 2007, 5:1-10.
15. Kallio M.J., McCleland M.L., Stukenberg P.T., Gorbsky G.J. Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis. Curr. Biol. 2002, 12:900-905.
16. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315.
17. Tamm C., Bower N., Anneren C. Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J Cell Sci 2011, 124:1136-1144.
18. Bursell L., Woods A., James C.G., Pala D., Leask A., Beier F. Src kinase inhibition promotes the chondrocyte phenotype. Arthritis Res. Ther. 2007, 9:R105.
19. Lee M., Kim J.Y., Koh W.S. Apoptotic effect of PP2 a Src tyrosine kinase inhibitor, in murine B cell leukemia. J. Cell. Biochem. 2004, 93:629-638.
20. Nam J.S., Ino Y., Sakamoto M., Hirohashi S. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Clin. Cancer Res. 2002, 8:2430-2436.
21. Blake R.A., Garcia-Paramio P., Parker P.J., Courtneidge S.A. Src promotes PKCdelta degradation. Cell Growth Differ. 1999, 10:231-241.
22. Tatton L., Morley G.M., Chopra R., Khwaja A. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. J. Biol. Chem. 2003, 278:4847-4853.
23. Dorsey J.F., Cunnick J.M., Lanehart R., Huang M., Kraker A.J., Bhalla K.N., Jove R., Wu J. Interleukin-3 protects Bcr-Abl-transformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors. Leukemia 2002, 16:1589-1595.
24. Palumbo R., De Marchis F., Pusterla T., Conti A., Alessio M., Bianchi M.E. Src family kinases are necessary for cell migration induced by extracellular HMGB1. J. Leukoc. Biol. 2009, 86:617-623.
25. de la Barre A.E., Gerson V., Gout S., Creaven M., Allis C.D., Dimitrov S. Core histone N-termini play an essential role in mitotic chromosome condensation. EMBO J. 2000, 19:379-391.
26. Nigg E.A. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol. 2001, 2:21-32.
27. Wei Y., Yu L., Bowen J., Gorovsky M.A., Allis C.D. Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 1999, 97:99-109.
28. Roninson I.B., Broude E.V., Chang B.D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist. Updat. 2001, 4:303-313.
29. Mathon N.F., Lloyd A.C. Cell senescence and cancer. Nat. Rev. Cancer 2001, 1:203-213.
30. Narita M., Lowe S.W. Senescence comes of age. Nat. Med. 2005, 11:920-922.
31. Hau P.M., Siu W.Y., Wong N., Lai P.B., Poon R.Y. Polyploidization increases the sensitivity to DNA-damaging agents in mammalian cells. FEBS Lett. 2006, 580:4727-4736.
32. Kim K.W., Mutter R.W., Willey C.D., Subhawong T.K., Shinohara E.T., Albert J.M., Ling G., Cao C., Gi Y.J., Lu B. Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:1519-1525.
33. Tsuno T., Natsume A., Katsumata S., Mizuno M., Fujita M., Osawa H., Nakahara N., Wakabayashi T., Satoh Y., Inagaki M., Yoshida J. Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells. J. Neurooncol. 2007, 83:249-258.
34. Cuneo K.C., Geng L., Tan J., Brousal J., Shinohara E.T., Osusky K., Fu A., Shyr Y., Wu H., Hallahan D.E. SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64:1197-1203.
35. Dressman H.K., Berchuck A., Chan G., Zhai J., Bild A., Sayer R., Cragun J., Clarke J., Whitaker R.S., Li L., Gray J., Marks J., Ginsburg G.S., Potti A., West M., Nevins J.R., Lancaster J.M. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. J. Clin. Oncol. 2007, 25:517-525.
36. Abu-Ghazaleh R., Kabir J., Jia H., Lobo M., Zachary I. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem. J. 2001, 360:255-264.
37. Yin T., Getsios S., Caldelari R., Kowalczyk A.P., Muller E.J., Jones J.C., Green K.J. Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5420-5425.
38. Sossey-Alaoui K., Li X., Cowell J.K. c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia formation and cell migration. J. Biol. Chem. 2007, 282:26257-26265.
39. Yu J., Moon A., Kim H.R. Both platelet-derived growth factor receptor (PDGFR)-alpha and PDGFR-beta promote murine fibroblast cell migration. Biochem. Biophys. Res. Commun. 2001, 282:697-700.
40. Velling T., Nilsson S., Stefansson A., Johansson S. Beta1-integrins induce phosphorylation of Akt on serine 473 independently of focal adhesion kinase and Src family kinases. EMBO Rep. 2004, 5:901-905.
41. Zeller K.S., Idevall-Hagren O., Stefansson A., Velling T., Jackson S.P., Downward J., Tengholm A., Johansson S. PI3-kinase p110alpha mediates beta1 integrin-induced Akt activation and membrane protrusion during cell attachment and initial spreading. Cell. Signal. 2010, 22:1838-1848.
42. Zhao B., Lei Q.Y., Guan K.L. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr. Opin. Cell Biol. 2008, 20:638-646.
43. Ota M., Sasaki H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 2008, 135:4059-4069.
44. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., Melton D.A. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 2002, 298:597-600.
45. Sudol M., Bork P., Einbond A., Kastury K., Druck T., Negrini M., Huebner K., Lehman D. Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J. Biol. Chem. 1995, 270:14733-14741.
46. Zeng Q., Hong W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 2008, 13:188-192.
47. Lian I., Kim J., Okazawa H., Zhao J., Zhao B., Yu J., Chinnaiyan A., Israel M.A., Goldstein L.S., Abujarour R., Ding S., Guan K.L. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 2010, 24:1106-1118.